Found 12 results

Author Title Type [ Year]

Filters: Author is Chew, Emily Y  [Clear All Filters]

2018

E. Y. Chew, Clemons, T. E., Jaffe, G. J., Johnson, C. A., Farsiu, S., Lad, E. M., Guymer, R., Rosenfeld, P., Hubschman, J. - P., Constable, I., Wiley, H., Singerman, L. J., Gillies, M., Comer, G., Blodi, B., Eliott, D., Yan, J., Bird, A., and Friedlander, M., “Effect of Ciliary Neurotrophic Factor on Retinal Neurodegeneration in Patients with Macular Telangiectasia Type 2: A Randomized Clinical Trial.”, Ophthalmology, 2018.

Q. Yan, Ding, Y., Liu, Y., Sun, T., Fritsche, L. G., Clemons, T., Ratnapriya, R., Klein, M. L., Cook, R. J., Liu, Y., Fan, R., Wei, L., Abecasis, G. R., Swaroop, A., Chew, E. Y., Weeks, D. E., and Chen, W., “Genome-wide analysis of disease progression in age-related macular degeneration.”, Hum Mol Genet, vol. 27, no. 5, pp. 929-940, 2018.

J. J. Yu, Agrόn, E., Clemons, T. E., Domalpally, A., van Asten, F., Keenan, T. D., Cukras, C., and Chew, E. Y., “Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17.”, Ophthalmology, 2018.

U. E. K. Wolf-Schnurrbusch, Leung, I., Sallo, F. B., Clemons, T. E., Chew, E. Y., Bird, A. C., and Peto, T., “Potential Effects of Hormone Therapy in Type 2 Idiopathic Macular Telangiectasia.”, Ophthalmic Res, vol. 60, no. 1, pp. 38-42, 2018.

2017

F. B. Sallo, Leung, I., Zeimer, M., Clemons, T. E., Dubis, A. M., Fruttiger, M., Pauleikhoff, D., Chew, E. Y., Egan, C., Peto, T., and Bird, A. C., “Abnormal Retinal Reflectivity to Short-Wavelength Light in Type 2 Idiopathic Macular Telangiectasia”, Retina, 2017.

C. Papudesu, Clemons, T. E., Agrón, E., and Chew, E. Y., “Association of Mortality with Ocular Diseases and Visual Impairment in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 13”, Ophthalmology, 2017.

T. Peto, Heeren, T. F. C., Clemons, T. E., Sallo, F. B., Leung, I., Chew, E. Y., and Bird, A. C., “Correlation of Clinical and Structural Progression with Visual Acuity Loss in Macular Telangiectasia Type 2: MacTel Project Report No. 6-The MacTel Research Group”, Retina, 2017.

F. B. Sallo, Leung, I., Clemons, T. E., Peto, T., Chew, E. Y., Pauleikhoff, D., and Bird, A. C., “Correlation of Structural and Functional Outcome Measures in A Phase One Trial of Ciliary Neurotrophic Factor in Type 2 Idiopathic Macular Telangiectasia”, Retina, 2017.

F. van Asten, Simmons, M., Singhal, A., Keenan, T. D., Ratnapriya, R., Agrón, E., Clemons, T. E., Swaroop, A., Lu, Z., and Chew, E. Y., “A Deep Phenotype Association Study Reveals Specific Phenotype Associations with Genetic Variants in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 (AREDS2) Report No. 14”, Ophthalmology, 2017.

T. F. C. Heeren, Kitka, D., Florea, D., Clemons, T. E., Chew, E. Y., Bird, A. C., Pauleikhoff, D., Issa, P. Charbel, Holz, F. G., and Peto, T., “Longitudinal Correlation of Ellipsoid Zone Loss and Functional Loss in Macular Telangiectasia Type 2”, Retina, 2017.

K. Sleiman, Veerappan, M., Winter, K. P., McCall, M. N., Yiu, G., Farsiu, S., Chew, E. Y., Clemons, T., and Toth, C. A., “Optical Coherence Tomography Predictors of Risk for Progression to Non-Neovascular Atrophic Age-Related Macular Degeneration”, Ophthalmology, 2017.

2015

E. Y. Chew, Clemons, T. E., Agrón, E., Launer, L. J., Grodstein, F., and Bernstein, P. S., “Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial”, JAMA, vol. 314, no. 8, pp. 791-801, 2015.